BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33385275)

  • 1. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.
    Sunami K; Naito Y; Aimono E; Amano T; Ennishi D; Kage H; Kanai M; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Yoshino T
    Int J Clin Oncol; 2021 Mar; 26(3):443-449. PubMed ID: 33385275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronological improvement in precision oncology implementation in Japan.
    Sunami K; Naito Y; Komine K; Amano T; Ennishi D; Imai M; Kage H; Kanai M; Kenmotsu H; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Saigusa Y; Yoshino T
    Cancer Sci; 2022 Nov; 113(11):3995-4000. PubMed ID: 35976133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
    Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Challenges in Expert Panel].
    Yachida S
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):994-996. PubMed ID: 36156023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Precision Medicine Provided by National Health Insurance].
    Muto M; Kondo T; Matsubara J; Kanai M; Matsumoto S; Ashida K; Suga J; Mukai K
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1158-1163. PubMed ID: 32829347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan.
    Kage H; Oda K; Muto M; Tsuchihara K; Okita N; Okuma Y; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Sakai D; Hirasawa A; Kubo M; Kenmotsu H; Akiyama N; Shinozaki-Ushiku A; Tanabe M; Ushiku T; Miyagawa K; Seto Y
    Cancer Sci; 2023 Jul; 114(7):3041-3049. PubMed ID: 37165760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current Status and Prospects of the Comprehensive Cancer Genome Profiling].
    Imoto I; Fukue M; Takaiso N
    Gan To Kagaku Ryoho; 2021 Jan; 48(1):7-11. PubMed ID: 33468714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan.
    Kanai M
    Curr Oncol; 2022 Sep; 29(10):7272-7284. PubMed ID: 36290850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan.
    Kage H; Shinozaki-Ushiku A; Ishigaki K; Sato Y; Tanabe M; Tanaka S; Tanikawa M; Watanabe K; Kato S; Akagi K; Uchino K; Mitani K; Takahashi S; Miura Y; Ikeda S; Kojima Y; Watanabe K; Mochizuki H; Yamaguchi H; Kawazoe Y; Kashiwabara K; Kohsaka S; Tatsuno K; Ushiku T; Ohe K; Yatomi Y; Seto Y; Aburatani H; Mano H; Miyagawa K; Oda K
    Cancer Sci; 2023 Apr; 114(4):1710-1717. PubMed ID: 36601953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and implementation of Cancer Genomic Medicine in Japan.
    Mukai Y; Ueno H
    Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient survey on cancer genomic medicine in Japan under the national health insurance system.
    Kage H; Akiyama N; Chang H; Shinozaki-Ushiku A; Ka M; Kawata J; Muto M; Okuma Y; Okita N; Tsuchihara K; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Yachida S; Hirasawa A; Kubo M; Kenmotsu H; Tanabe M; Ushiku T; Muto K; Seto Y; Oda K
    Cancer Sci; 2024 Mar; 115(3):954-962. PubMed ID: 38273803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.
    Kikuchi J; Ohhara Y; Takada K; Tanabe H; Hatanaka K; Amano T; C Hatanaka K; Hatanaka Y; Mitamura T; Kato M; Shibata Y; Yabe I; Endoh A; Komatsu Y; Matsuno Y; Sugiyama M; Manabe A; Sakurai A; Takahashi M; Naruse H; Torimoto Y; Dosaka-Akita H; Kinoshita I
    Jpn J Clin Oncol; 2021 Apr; 51(5):753-761. PubMed ID: 33532831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Sunami K
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of a System for Providing Cancer Genomic Medicine in Hokkaido-From the Standpoint of a Designated Core Hospital for Cancer Genomic Medicine].
    Kinoshita I; Kikuchi J; Ohhara Y; Amano T; Akita H
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):882-886. PubMed ID: 34267021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interinstitutional Collaboration for Molecular Tumor Boards].
    Komine K; Shirota H
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):626-629. PubMed ID: 31164497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Roles of Designated Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Nishida T
    Gan To Kagaku Ryoho; 2018 Sep; 45(9):1223-1227. PubMed ID: 30237359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan.
    Kohno T; Kato M; Kohsaka S; Sudo T; Tamai I; Shiraishi Y; Okuma Y; Ogasawara D; Suzuki T; Yoshida T; Mano H
    Cancer Discov; 2022 Nov; 12(11):2509-2515. PubMed ID: 36321305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice.
    Ida H; Koyama T; Mizuno T; Sunami K; Kubo T; Sudo K; Tao K; Hirata M; Yonemori K; Kato K; Okusaka T; Ohe Y; Matsui Y; Yamazaki N; Ogawa C; Kawai A; Narita Y; Esaki M; Yamamoto N
    Cancer Sci; 2022 Dec; 113(12):4300-4310. PubMed ID: 36106376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan.
    Naito Y; Sunami K; Kage H; Komine K; Amano T; Imai M; Koyama T; Ennishi D; Kanai M; Kenmotsu H; Maeda T; Morita S; Sakai D; Watanabe K; Shirota H; Kinoshita I; Yoshioka M; Mamesaya N; Ito M; Kohsaka S; Saigusa Y; Yamamoto K; Hirata M; Tsuchihara K; Yoshino T
    JAMA Netw Open; 2022 Dec; 5(12):e2245081. PubMed ID: 36469316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.